title: Current developments in avian influenza vaccines, including safety of vaccinated birds as food.
abstract: Until recently, most vaccines against avian influenza were based on oil-emulsified inactivated low- or high-pathogenicity viruses. Now, recombinant fowl pox and avian paramyxovirus type 1 vaccines with avian influenza H5 gene inserts (+ or - N1 gene insert) are available and licensed. New technologies might overcome existing limitations to make available vaccines that can be grown in tissue culture systems for more rapid production; provide optimized protection, as a result of closer genetic relations to field viruses; allow mass administration by aerosol, in drinking-water or in ovo; and allow easier strategies for identifying infected birds within vaccinated populations (DIVA). The technologies include avian influenza viruses with partial gene deletions, avian influenza-Newcastle disease virus chimeras, vectored vaccines such as adenoviruses and Marek's disease virus, and subunit vaccines. These new methods should be licensed only after their purity, safety, efficacy and potency against avian influenza viruses have been demonstrated, and, for live vectored vaccines, restriction of viral transmission to unvaccinated birds. Use of vaccines in countries affected by highly pathogenic avian influenza will not only protect poultry but will provide additional safety for consumers. Experimental studies have shown that birds vaccinated against avian influenza have no virus in meat and minimal amounts in eggs after HPAI virus challenge, and that replication and shedding from their respiratory and alimentary tracts is greatly reduced.
authors.affiliation: Southeast Poultry Research Laboratory, Agricultural Research Service, Department of Agriculture, Athens, Georgia 30605, USA. David.Swayne@ars.usda.gov
authors.forename: D E
authors.initials: DE
authors.lastname: Swayne
authors.forename: D L
authors.initials: DL
authors.lastname: Suarez
mesh_terms: D000818:Animals; D004531:Eggs / Q000592:standards / Q000821:virology*; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology* / Q000302:isolation & purification; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D005585:Influenza in Birds / Q000517:prevention & control*; D008460:Meat / Q000592:standards / Q000821:virology*; D011200:Poultry; D014611:Vaccination / Q000009:adverse effects / Q000592:standards / Q000662:veterinary
chemical_list: D007252:Influenza Vaccines